BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, July 23, 2026
Home » Blogs » BioWorld Perspectives » Venter, Watson Warm Up for Clash of the Titans

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld / EMA

Venter, Watson Warm Up for Clash of the Titans

July 10, 2012
By Cormac Sheridan

DUBLIN ‑ Europe's biggest scientific carnival is pitching its tent beside the River Liffey this week. Dublin is playing host to the Euroscience Open Forum (ESOF) 2012 meeting and, thereby, assumes the mantle of Europe's City of Science for the year.

Conceived as Europe's answer to the annual meeting of the American Association for the Advancement of Science, ESOF has become an increasingly visible element in Europe's efforts to foster a shared scientific identity. Although different European countries have vastly differing scientific heritages, their scientific futures are converging, thanks to an increasing level of recognition, both in Brussels and across the continent, that the region can only compete on a global basis if it acts in concert.

Ireland's bid to host the event was originally conceived as its coming of age as a location for high quality scientific research, following an expansive strategy that began just over a decade ago. At present, however, the mood is not entirely celebratory. The present government's commitment to open-ended, blue-skies research has wavered, following a catastrophic banking collapse in 2008, which culminated in the country entering a bailout program administered by the International Monetary Fund and the European Central Bank. Although funding for science has held up, just about, a recent sharp turn to a more industrially focused research agenda has been met with anger and dismay by some of the country's leading scientists.

Even so, there will be plenty to celebrate in Dublin this week ‑ in terms of both homegrown successes and the very best of international science. The recent (apparent) detection of the Higgs boson at CERN, in Geneva, will provide one important focus for the meeting. CERN's director general Rolf Heuer will be in town. But the physicists will have to share the limelight with a clutch of heavyweights from the life sciences world, including Nobel laureates Jules Hoffman (2011), Peter Doherty (1996), Torsten Niels Wiesel (1981) and James Watson (1962).

One event of interest to both camps will be Craig Venter's What is Life lecture at Trinity College Dublin on Thursday evening. This will commemorate the original 1943 lecture series by Erwin Schroedinger, one of the founders of quantum mechanics, who spent 14 years in Dublin during and after the Second World War. Schroedinger's book of the same name, which appeared in 1944, was a key text in the early development of molecular biology and a source of inspiration for James Watson and Francis Crick. Watson will be on hand to respond to Venter's address. It might be an exaggeration to dub the event Clash of the Titans, but it's an intriguing prospect nonetheless.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 21, 2026
  • Red CAR T cell on blue blackground

    To viral or not to viral: In vivo CAR T debates delivery tech

    BioWorld
    The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
  • Tree in the shape of human head losing leaves

    KBN-2201 reverses key features of Alzheimer’s in mice

    BioWorld Science
    Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
  • Click chemistry drug bound to pancreatic cancer cells from mice

    In vivo click ADCs could address tumor heterogeneity

    BioWorld
    Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing